Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)

News provided by

Research and Markets

23 Sep, 2014, 16:01 GMT

DUBLIN, Sept. 23, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Continue Reading
This image opens in the lightbox
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

This report defines markets and identifies trends for proteomics applications, both in their research use and in IVD. Proteomics is the study of proteins, including the study of the structure and function of proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on research markets but has applications in therapeutics and diagnostics.

Understanding the human proteome is a much larger and more challenging task than the Human Genome Project was. The proteome is much more complex as it can change based on factors that affect which genes are expressed. Also, after proteins are expressed, proteins may be modified. Proteomics will remain a very active area of research for several years, and the knowledge derived from this research is expected to produce advances in the diagnosis and treatment of diseases.r decades, many advances are being made in this field. Other major technology segments include chromatography, electrophoresis, microarrays, and other technologies.

Companies discussed in this report include those who with proteomics platforms and related products, commercializing technologies such as mass spectrometry or other proteomics technologies. In addition, this report discusses the proteomics research, services, and products developed and marketed by companies using these proteomics technologies and platforms. Many of the companies in this second group have developed their own proprietary proteomic technologies that utilize technologies such as mass spectrometry or other proteomic technologies.

Key Topics Covered:

CHAPTER ONE: EXECUTIVE SUMMARY

CHAPTER TWO: INTRODUCTION

CHAPTER THREE: TECHNOLOGIES

CHAPTER FOUR: PROTEOMICS APPLICATIONS

CHAPTER FIVE: INVESTMENTS AND FINANCING AGREEMENTS FOR PROTEOMICS COMPANIES

CHAPTER SIX: CONSORTIA

CHAPTER SEVEN: ISSUES AND TRENDS

CHAPTER EIGHT: MARKET ANALYSIS

CHAPTER NINE: COMPANIES MARKETING OR DEVELOPING PROTEOMICS TOOLS AND PLATFORMS

  • Abbott Laboratories
  • AB SCIEX (A Danaher Corporation Company)
  • ActivX Biosciences, Inc. (Owned by Kyorin Pharmaceuticals)
  • Advion, Inc.
  • Affymetrix, Inc.
  • Arbor Vita Corporation
  • ArcDia International Oy Ltd
  • Arrayit Corporation
  • Atonomics A/S
  • Avant Diagnostics, Inc.
  • Axela, Inc.
  • AXO Science
  • AYOXXA Biosystems GmbH
  • Banyan Biomarkers
  • Beckman Coulter, Inc.
  • (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (BD)
  • BG Medicine, Inc.
  • BioAnalyte Inc.
  • Biocartis SA
  • Biodesix, Inc.
  • Biognosys AG
  • bioMérieux SA
  • BioMosaics Inc.
  • Bioproximity, LLC
  • Bio-Rad Laboratories, Inc.
  • Biosensia Ltd.
  • BioSystems International
  • Bruker Corporation
  • Cambridge Protein Arrays Ltd.
  • Caprion, Inc.
  • caprotec bioanalytics GmbH
  • CardioGenics Holdings, Inc.
  • CD Diagnostics, Inc.
  • CDI Laboratories
  • Chromsystems Instruments & Chemicals GmbH
  • Clearbridge BioLoc Pte Ltd.
  • Courtagen Life Sciences, Inc.
  • CovalX AG
  • CRELUX GmbH
  • Crescendo Bioscience (Subsidiary of Myriad Genetics)
  • CyVek Inc.
  • Danaher Corporation
  • Dasit Group - Focusing on
  • DECODON GmbH
  • DiAssess Inc.
  • Digilab, Inc.
  • Dualsystems Biotech AG
  • EMD
  • Euroimmun AG
  • Evotec AG
  • Expedeon, Inc.
  • Fluidigm
  • Fujirebio Inc.
  • GE Healthcare Life Sciences
  • Genalyte, Inc.
  • GeneFluidics, Inc.
  • Geneva Bioinformatics (GeneBio) SA
  • GWC Technologies
  • Helena Laboratories
  • Hoefer, Inc. (Subsidiary of Harvard Bioscience, Inc.)
  • Hybrigenics SA
  • ImaBiotech SAS
  • Immunexpress Group
  • Immunovia AB
  • InDevR, Inc.
  • Insilicos LLC
  • Integrated Diagnostics, Inc.
  • Integromics S.L.
  • Intuitive Biosciences, Inc.
  • JOEL Ltd.
  • KineMed, Inc.
  • Kinexus
  • LEAP Technologies, Inc.
  • Life Technologies Corporation
  • LSI Medience Corporation
  • Luminex Corporation
  • MagArray Inc.
  • Matrix Science Limited
  • MBio Diagnostics, Inc.
  • Microlytic ApS
  • QuantiScientifics, LLC
  • Quidel Corporation
  • Rigaku Reagents, Inc.
  • Roche Diagnostics
  • Sebia, Inc.
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare Diagnostics
  • Sigma-Aldrich Corporation
  • Singulex, Inc.
  • SISCAPA Assay Technologies, Inc.
  • SomaLogic, Inc.
  • SpOtOn Clinical Diagnostics Limited
  • SQI Diagnostics Inc.
  • STAT-Diagnostica
  • Syngene (Division of Synoptics Ltd)
  • T2 Biosystems, Inc.
  • Tecan Group AG
  • The Binding Site Group Ltd.
  • Theranostics Health Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Venaxis, Inc. (Formerly Aspen BioPharma, Inc.)
  • Wako Diagnostics
  • Waters Corporation

For more information visit http://www.researchandmarkets.com/research/sccg6n/proteomics

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net